Decreased plasma level of vitamin C in chronic kidney disease: Comparison between diabetic and non-diabetic patients

Nephrology Dialysis Transplantation

Volumn 26, Issue 4, 2011, Pages 1252-1257

  Takahashi, Nobuyuki ^a   Morimoto, Satoshi ^a   Okigaki, Mitsuhiko ^b   Seo, Maiko ^a   Someya, Kazunori ^a   Morita, Tatsuyori ^a   Matsubara, Hiroaki ^b   Sugiura, Tetsuro ^c   Iwasaka, Toshiji ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

endothelial function; estimated glomerular filtration rate; flow mediated dilatation; malondialdehyde low density lipoprotein; vitamin C

Indexed keywords

ALBUMIN; ASCORBIC ACID; C REACTIVE PROTEIN; CREATININE; DIURETIC AGENT; HEMOGLOBIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; POTASSIUM; UREA;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BODY MASS; BRACHIAL ARTERY; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN URINE LEVEL; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL; VASODILATATION;

AGED; AGED, 80 AND OVER; ANTIOXIDANTS; ASCORBIC ACID; ASCORBIC ACID DEFICIENCY; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 79953893321     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq547     Document Type: Article

References (28)

1. Sarnak MJ, Levey AS, Schoolwerth AC et al. American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108: 2154-2169 (Pubitemid 37337595)
2. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305
3. Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrol 2004; 15: 1983-1992 (Pubitemid 39031337)
4. Chade AR, Lerman A, Lerman LO. Kidney in early atherosclerosis. Hypertension 2005; 45: 1042-1049 (Pubitemid 40770301)
5. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000; 87: 840-844
6. Massy ZA, Nguyen-Khoa T. Oxidative stress and chronic renal failure: markers and management. J Nephrol 2002; 15: 336-341
7. Locatelli F, Canaud B, Eckardt KU et al. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant 2003; 18: 1272-1280 (Pubitemid 36826946)
8. Aguirre R, May JM. Inflammation in the vascular bed: importance of vitamin C. Pharmacol Ther 2008; 119: 96-103
9. Padh H. Vitamin C: newer insights into its biochemical functions. Nutr Rev 1991; 49: 65-70
10. Fletcher AE, Breeze E, Shetty PS. Antioxidant vitamins and mortality in older persons: findings from the nutrition add-on study to the Medical Research Council Trial of Assessment and Management of Older People in the Community. Am J Clin Nutr 2003; 78: 999-1010 (Pubitemid 39663478)
11. Deicher R, Ziai F, Bieglmayer C et al. Low total vitamin C plasma level is a risk factor for cardiovascular morbidity and mortality in hemodialysis patients. J Am Soc Nephrol 2005; 16: 1811-1818 (Pubitemid 41716488)
12. Wolf G. New insight into the pathophysiology of diabetic nephropa-thy: from haemodynamics to molecular pathology. Eur J Clin Invest 2004; 34: 785-796 (Pubitemid 39657924)
13. Matsuo S, Imai E, Horio M et al. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-992
14. Corretti MC, Anderson TJ, Benjamin EJ et al. International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilatation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39: 257-265 (Pubitemid 34084631)
15. Lykkesfeldt J, Loft S, Poulsen HE. Determination of ascorbic acid and dehydroascorbic acid in plasma by high-performance liquid chro-matography with coulometric detection-are they reliable biomarkers of oxidative stress? Anal Biochem 1995; 229: 329-335
16. Kitano S, Kano T, Maekawa M et al. Improved method for the im-munological detection of malondialdehyde-modified low-density li-poproteins in human serum. Anal Chim Acta 2004; 509: 229-235 (Pubitemid 38340721)
17. Deicher R, Hörl WH. Vitamin C in chronic kidney disease and hemodialysis patients. Kidney Blood Press Res 2003; 26: 100-106 (Pubitemid 36677066)
18. Singer R, Rhodes HC, Chin G et al. High prevalence of ascorbate deficiency in an Australian peritoneal dialysis population. Nephrology 2008; 13: 17-22
19. May JM, Qu ZC, Whitesell RR et al. Ascorbate recycling in human erythrocytes: role of GSH in reducing dehydroascorbate. Free Radic Biol Med 1996; 20: 543-551 (Pubitemid 26097271)
20. Mydlík M, Derzsiová K, Zemberová E. Influence of water and sodium diuresis and furosemide on urinary excretion of vitamin B(6), oxalic acid and vitamin C in chronic renal failure. Miner Electrolyte Metab 1999; 25: 352-356 (Pubitemid 30099691)
21. Hirsch IB, Atchley DH, Tsai E et al. Ascorbic acid clearance in diabetic nephropathy. J Diabetes Complications 1998; 12: 259-263 (Pubitemid 28423396)
22. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-1695
23. Saeed RW, Peng T, Metz CN. Ascorbic acid blocks the growth inhibitory effect of tumor necrosis factor-alpha on endothelial cells. Exp Biol Med 2003; 228: 855-865 (Pubitemid 37169272)
24. Recchioni R, Marcheselli F, Moroni Fet al. Apoptosis in human aortic endothelial cells induced by hyperglycemic condition involves mitochondrial depolarization and is prevented by N-acetyl-L-cysteine. Metabolism 2002; 51: 1384-1388
25. May JM. How does ascorbic acid prevent endothelial dysfunction? Free Radic Biol Med 2000; 28: 1421-1429 (Pubitemid 30621484)
26. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA 1989; 86: 6377-6381 (Pubitemid 19210655)
27. Boaz M, Matas Z, Biro A et al. Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis. Kidney Int 1999; 56: 1078-1083 (Pubitemid 29411736)
28. Bucala R, Tracey KJ, Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 1991; 87: 432-438